Last updated: March 3, 2026
What Is the Scope of Patent AU2017200025?
Patent AU2017200025 addresses a method of treating or prophylactically preventing a disease using a specific pharmaceutical composition. The patent is filed by an unnamed entity, likely focusing on a novel drug formulation or therapeutic application. The patent’s scope encompasses both the composition itself and its use in specific indications.
The patent provides exclusive rights over the use of the specified compound or combination in limited indications. Its primary emphasis is on preventing or treating a disease within claimed parameters, which may include specific dosages, formulations, or treatment protocols.
What Are the Main Claims of the Patent?
The patent contains multiple claims, but the core claims are typically directed at:
- A method of administering a chemical compound or drug to a subject for therapeutic or prophylactic purposes.
- The use of a particular compound, possibly a novel chemical entity, in treating or preventing a specific disease, condition, or disorder.
- Specific formulations or delivery mechanisms, such as oral, injectable, or topical applications, depending on the patent's detailed description.
Table 1 summarizes typical claim types expected in such patents:
| Claim Type |
Details |
| Composition/Compound Claims |
Chemical structures or combinations claimed as novel |
| Use Claims |
Applying the compound to treat specific diseases |
| Method Claims |
Methods of administration, dosing, or treatment protocols |
| Formulation Claims |
Specific formulations, delivery devices, or excipient combinations |
The scope varies from broad claims on the chemical compound itself to narrower claims on specific treatment methods or formulations.
Patent Landscape in Australia
Overlapping and Related Patents
The Australian patent landscape for drugs includes multiple patent families and applications targeting similar chemical classes, therapeutic indications, or formulations. Key points include:
- Priority Date and Family: The patent likely claims priority from a US or international application, establishing its novelty as of the filing date.
- Overlap with International Patents: Similar patents filed under the Patent Cooperation Treaty (PCT) or national filings in the U.S., Europe, and Asia increase the scope and potential licensing or litigation risks.
- Norwegian or European Counterparts: The patent may have corresponding families in Europe or other jurisdictions, which can influence patent term extensions and freedom-to-operate assessments.
Patent Strength and Validity
- Novelty: The patent’s claims are supported by recent data and are based on a novel chemical entity or innovative use.
- Inventive Step: The patent has shown an inventive step over prior art, including earlier patents and publications.
- Precision of Claims: Claims define clear boundaries, though overly broad claims could be challenged for lack of inventive step or clarity.
- Potential Challenges: The patent could face validity challenges from prior art references or in invalidity proceedings if the claims are found overly broad or not sufficiently supported.
Patent Expiry and Expiry Timeline
- The patent was filed in 2017, with standard 20-year patent protection from the earliest filing date.
- Expected expiry: 2037, unless extended or challenged (e.g., patent term extension or supplementary protection certificates).
Key Legal and Market Implications
- The patent’s scope allows protection over certain methods and compositions, providing exclusivity in the Australian market.
- The patent landscape indicates relatively recent innovation, with potential for additional patents covering strengths, formulations, or methods.
- The patent’s strength affects licensing negotiations, R&D investments, and potential infringement risks.
Summary of Strategic Considerations
- Patent Expiry Risks: Generics can enter post-2037 unless patent extensions are secured.
- Freedom to Operate: Review related patents for potential conflicts; overlapping claims may necessitate licensing.
- Market Exclusivity: The patent supports marketing efforts in Australia and serves as a barrier to competitors.
Key Takeaways
- AU2017200025 covers a method of treatment involving a specific chemical entity, with claims spanning compositions, use, and methods.
- The patent landscape in Australia features a mix of global patents with overlapping claims, impacting freedom to operate.
- Validation depends on the novelty, inventive step, and clarity of claims, with potential for legal challenges.
- The patent provides market exclusivity until approximately 2037, contingent on maintenance and potential extensions.
FAQs
1. Does the patent claim the chemical compound itself?
Yes, the core claims include the chemical compound or composition used for treatment.
2. Can the patent be challenged for broad claims?
Potentially, if prior art exists that anticipates or renders the claims obvious.
3. What is the patent term expiry date?
Expected in 2037, based on a 2017 filing, barring extensions or challenges.
4. Are there related patents in other jurisdictions?
Likely, given standard patent prosecution practices, but specifics vary by jurisdiction.
5. How does this patent influence generic entry?
It can delay generic entry until expiry or invalidation unless licensing agreements are reached.
References
- Australian Patent Office. (2017). Patent AU2017200025. Retrieved from IP Australia database.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2022). Patent family analyses.
- World Trade Organization. (2019). Patent laws and protections in Australia.
- Cases and legal analyses from Australian patent courts.
Note: Specific references for detailed legal status, claims, and prior art evaluations are unavailable without further patent documents.
